Related references
Note: Only part of the references are listed.Receptor for advanced glycation endproducts and progressive kidney disease
Kei Fukami et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
A. Ojima et al.
HORMONE AND METABOLIC RESEARCH (2015)
The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
Matthias Oelze et al.
PLOS ONE (2014)
Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes
Nasser Mikhail
WORLD JOURNAL OF DIABETES (2014)
Sodium-glucose cotransporter 2-mediated oxidative stress augments advanced glycation end products-induced tubular cell apoptosis
Sayaka Maeda et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2013)
Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus
Volker Vallon et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences
Ivan Sabolic et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
Giovanni Musso et al.
ANNALS OF MEDICINE (2012)
Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats
Horacio Osorio et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury
Yuji Ishibashi et al.
PHARMACOLOGICAL RESEARCH (2012)
Insulin Resistance, Obesity, Hypertension, and Renal Sodium Transport
Shoko Horita et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2011)
Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
Rene Santer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Reactive Oxygen Species Promote Caspase-12 Expression and Tubular Apoptosis in Diabetic Nephropathy
Marie-Luise Brezniceanu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Clifford J. Bailey et al.
LANCET (2010)
Advanced glycation end products, oxidative stress and diabetic nephropathy
Sho-ichi Yamagishi et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2010)
Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression
Takanori Matsui et al.
PHARMACOLOGICAL RESEARCH (2010)
Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats
Horacio Osorio et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Expression and Activity of SGLT2 in Diabetes Induced by Streptozotocin: Relationship with the Lipid Environment
Maria F. Albertoni Borghese et al.
NEPHRON PHYSIOLOGY (2009)
Insulin inhibits caspase-3 activity in human renal tubular epithelial cells via the PI3-kinase/Akt pathway
Markus Meier et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Na+-glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels:: Involvement of hepatocyte nuclear factor-1α expression and activity
H. S. Freitas et al.
ENDOCRINOLOGY (2008)
Prevalence of atubular glomeruli in type 2 diabetic patients with nephropathy
Kathryn E. White et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes
Peter H. Sugden et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression
Sho-ichi Yamagishi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes
H Rahmoune et al.
DIABETES (2005)
Redox paradox - Insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets
BJ Goldstein et al.
DIABETES (2005)
Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy
S Yamagishi et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Advanced glycation end products inhibit de novo protein synthesis and induce TGF-β overexpression in proximal tubular cells
S Yamagishi et al.
KIDNEY INTERNATIONAL (2003)
Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of mic-rovascular complications in patients with Type 1 diabetes
J Miura et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2003)
The role of oxidative stress in the ochratoxin A-mediated toxicity in proximal tubular cells
GJ Schaaf et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
Reactive oxygen species as intracellular messengers during cell growth and differentiation
H Sauer et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2001)
Share Paper
